Yuichi Watanabe Osha Liang LLP January 26, 2016 Practice Tips: Prosecution of Japan-origin US applications 1 © AIPLA 2015.

Slides:



Advertisements
Similar presentations
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
Advertisements

Michael Neas Supervisor Office of PCT Legal Administration
Anatomy of a Patent Application Presented by: Jeong Oh Director, Office of Technology Transfer & Industrial Development Syracuse University April 30, 2009.
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
Disclaimer: The information provided by the USPTO is meant as an educational resource only and should not be construed as legal advice or written law.
JPO’s Reliance on Experimental Results in Patent Applications -From the Aspect of Requirements for Description of Claims and Specification- JPAA International.
JPO Updates JPAA International Activities Center Fujiko Shibata AIPLA Mid-Winter Institute IP Practice in Japan Committee Pre-Meeting Seminar.
AIPLA PPH Users Meeting May, 2010 Report on Patent Prosecution Highway Manny Schecter Chief Patent Counsel
Patent Cooperation Treaty (PCT) Amendment & Response Practice
Lauren MacLanahan Office of Technology Licensing GTRC.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Hamilton Beach Brands v. Sunbeam Products: Lessons Learned Naomi Abe Voegtli IP Practice.
1 35 U.S.C. § 102(e): The Legislative Fix (S.320) and Serial Abandonment of Provisional Applications Stephen G. Kunin Deputy Commissioner for Patent Examination.
1 United States Patent and Trademark Office Revised PCT International Search and Preliminary Examination Guidelines Biotech/ChemPharm Customer Partnership.
Information Disclosure Statements
December 8, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818)(upon enactment) and 35 U.S.C. 103(c) as Amended by.
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
New York | London | Munich | Sydney | Tokyo Cost-Effective International Patenting Strategies: Expand Your Global Opportunity Presented by Jeff Sweetman.
2 23,503 hours in FY 2013, compared with 21,273 hours in FY ,651 interview hours in FY 13 have been charged through the AFCP program. Interview.
35 USC 101 Update Business Methods Partnership Meeting, Spring 2008 by Robert Weinhardt Business Practice Specialist, Technology Center 3600
Contents of US Patent Applications & Filing Requirements
Dr. Michael Berger, European Patent Attorney © Michael Berger Intellectual Property (IP): Patents for Inventions.
1 1 Interview Practice Within the USPTO. 2 2 Topics Effective Interviews Reaching Agreement Requesting Interviews Issues Discussed Documenting Interviews.
Patents- Practical Aspects of International Patent Procurement/Prosecution June 2015 Patent Cooperation Treaty (PCT) Practice Overview.
International IP Issues Federal Lab Consortium Meeting International IP Issues Dr Roisin McNally - European Patent Attorney 20 September 2006.
Restriction & Double Patenting Mojdeh Bahar, J.D., M.A., CLP Chief, Cancer Branch Office of Technology Transfer National Institutes of Health U.S. Department.
1 LAW DIVISION PATENT DIVISION TRADEMARK & DESIGN DIVISION ACCOUNTING & AUDITING DIVISION YUASA AND HARA LAW, PATENT, TRADEMARK & DESIGN and ACCOUNTING.
Cost Effective Patent Prosecution at the EPO Dick Waddington Member of the International Liaison Committee (Non-European) Supporting logos to go in this.
Initial "Inventor" Interview (Practical Legal And Business Considerations) Greg Allen 3M Innovative Properties Company 1 August 26, 2010 AIPLA’s Practical.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Update regarding PCT and PPH at the USPTO Yuichi Watanabe Joint Meeting of AIPLA and.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
Heli PihlajamaaLondon, Director Patent Law (5.2.1) Clarity - Article 84 EPC.
Josiah Hernandez Patentability Requirements. Useful Having utilitarian or commercial value Novel No one else has done it before If someone has done it.
PCT FILING - ADVANTAGES© Dr. S. Padmaja, Managing Partner, iProPAT June 21, 2012.
Prosecution Lunch Patents January Reminder: USPTO Fee Changes- Jan. 1, 2014 Issue Fee Decrease- delay paying if you can –Issue Fee: from $1,780.
Post Grant Review to be introduced in Japan JPAA International Activities Center Fujiko Shibata January 29, 2013 AIPLA Mid-Winter Institute IP Practice.
Disunity before the EPO AIPLA Biotechnology committee March 17 th, 2011 Simon Wright BSc EPA CPA
Hamre, Schumann, Mueller & Larson, P.C U.S. Patent Claims By James A. Larson.
Revisions to Japanese Patent Law Before the law was revised, a Divisional Applications could not be filed after a Notice of Allowance 2.
1 1 1 AIPLA Firm Logo American Intellectual Property Law Association U.S. Implementation of the Hague Agreement For Designs John (Jack) J. Penny, V Event.
Patent Application – Invention name here Inventor: Your Name Assignee: Your Name Filed: Today’s date References Cited: Use Google Patent search to find.
2007 Revisions to Japanese Patent Law. 2 #1 Period for Filing Divisional Applications (A) BeforeBefore AfterAfter Notice of Allowance Divisional Application.
1 Biotech/Chem/Pharm Customer Partnership Meeting June 15, 2005 USPTO Study on Restriction Reform and Update on TC1600 Restriction Practice Action Plan.
Bruce Kisliuk Group Director, Technology Center 1600.
PCT PATENT COOPERATION TREATY By: Nico Reyes & Keziah Tan.
1/30 PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Patent filing and tips on patent drafting Makerere University – July 7, 2016 Kagwa John Marius – Examiner Patents.
TODAY’S GOALS Peer review the final draft of your podcast scripts Review the most important material from ENC1930.
PCT-FILING SYSTEM.
Preparing a Patent Application
Co-chairperson of Patents Committee
Patent application procedure (…and costs)
Options to Protect an Invention: the Patent Cooperation Treaty (PCT) and Trade Secrets Hanoi October 24, 2017 Peter Willimott Senior Program Officer WIPO.
Of Counsel Polsinelli, LLP
Drafting Mechanical Claims
Accelerating your Patent Prosecution in Mexico
Nuts and Bolts of Patent Law
Global Innovation Management Workout on Writing a Patent
Protection of Intellectual Property Resulting from STCU Projects
Doctrine of Equivalents
Comparing subject matter eligibility in us and eu
Protection of AI Inventions in Japan
Preparing a Patent Application
Article 34 Paperwork (Response to WO)
US Patent Applications
Subject Matter Eligibility
Claim drafting strategies when filing a European patent application or entering the European phase of a PCT-application Christof Keussen
TECHNICAL REPORTS WRITING
Jonathan D’Silva MMI Intellectual Property 900 State Street, Suite 301
Presentation transcript:

Yuichi Watanabe Osha Liang LLP January 26, 2016 Practice Tips: Prosecution of Japan-origin US applications 1 © AIPLA 2015

Drafting the original (Japanese) application  From US practice perspective  From translation perspective Filing options in the US  Convention application  PCT national phase application or “bypass” application Working with US agents/associates Outline - Practice tips regarding: 2 © AIPLA 2015

Drafting Japanese specification from US (or international) perspective  Keep the Background section short and concise o Avoid emphasizing disadvantages of the background art--instead, emphasize advantages of the invention in Detailed Description section o Avoid describing the “history” of how the inventors came up with the invention  Avoid describing what is NOT prior art o If you describe another person’s work as “prior art” anywhere in the specification, then your description can be used as admitted prior art even if it does not qualify under 35 U.S.C. 102 (MPEP 2129) Drafting original (Japanese) application 3 © AIPLA 2015

Drafting Japanese specification from US (or international) perspective – cont’d  Keep the Summary section short and concise o Best to mirror language of independent claims o Save details for Detailed Description section  Describe more than one embodiment o Generally, the more embodiments the better o Describe alternative embodiments even if they are less than ideal  Avoid descriptions with direct reference to “the preferred embodiment” or “the invention” Drafting original (Japanese) application 4 © AIPLA 2015

Drafting Japanese specification from US (or international) perspective – cont’d  Describe various structures for implementing the invention, even if the structural aspects of the invention are not novel o Identify not only the structural components, but also various physical attributes (e.g., inputs/outputs)  Avoid overly relying on knowledge of person skilled in the art o Particularly important when describing how to implement/practice the invention Drafting original (Japanese) application 5 © AIPLA 2015

Drafting Japanese claims from US (or international) perspective  Consider US claim format and claim construction rules o Use outline claim format, as opposed to narrative format o Avoid lengthy preambles or unnecessary repetition  Draft more than one independent claim, and draft claims directed to different categories or statutory classes o E.g., apparatus claims, method claims, composition claims, CRM (computer-readable medium) claims Drafting original (Japanese) application 6 © AIPLA 2015

Drafting Japanese claims from US (or international) perspective – cont’d  Avoid reciting terms/phrases that are not mentioned in the specification o Terms/phrases in claims should be consistent with terms/phrases in specification  Avoid terms/phrases that may invoke 35 U.S.C. 112(f) o Avoid “means” and “nonce” words (e.g., unit, module, section, part, etc.) modified by function (“configured to”) o For apparatus/device claims, recite structural features of the claim elements and structural relationship among those elements Drafting original (Japanese) application 7 © AIPLA 2015

Drafting the Japanese application from Translators ’ perspective  Use short, simple sentences  Be precise  Be consistent  Identify subject of each sentence  Clarify nouns as singular or plural  Avoid making up words or using uncommon words  Avoid useless verbiage Drafting original (Japanese) application 8 © AIPLA 2015

Direct (Paris Convention) route  File in any Paris Convention country within 12 months of original JP application filing date o May be more cost effective than PCT route when filing in three or fewer countries.  The US (English) application need not be a literal translation of JP application o US application can be revised (customized in view of US law and practice) as long as no new matter is introduced Filing options in the US 9 © AIPLA 2015

PCT route  File in any PCT country within 30 months (31 in some countries) of earliest filing date  Provides opportunity to evaluate prior art (cited in International Search Report/Written Opinion) and make amendments  Note: Paris Convention currently covers 176 countries, whereas Patent Cooperation Treaty covers 148 Filing options in the US 10 © AIPLA 2015

PCT route (two routes)  National phase route under 35 U.S.C. 371 o Treated as the same application as the PCT application (simply transferred from international phase to national phase) o If PCT application is not in English, then English translation (literal translation) must be submitted  “Bypass” continuation route under 35 U.S.C. 120, 363, and 365 o Treated as a separate application from the PCT application (i.e., treated like a regular US continuation application) o No need to submit literal translation of PCT application Filing options in the US 11 © AIPLA 2015

Advantages of bypass applications  Like Paris Convention applications, bypass applications can be freely revised “off the record” prior to filing (as long as no new matter is added) o National phase applications can be revised at time of filing, but only by way of preliminary amendment filed with USPTO  Substitute specification and marked-up specification also required when amending specification (volume of paperwork could be huge) Filing options in the US 12 © AIPLA 2015

Advantages of bypass applications – cont’d  In the past, bypass applications were processed more quickly than national phase applications (less true today)  Prior to America Invents Act (AIA), non-English PCT application publications were not given 35 U.S.C. 102(e) date o After AIA, 102(e) date no longer an issue Filing options in the US 13 © AIPLA 2015

Advantages of national phase applications  USPTO fees ($1480) slightly lower than bypass applications ($1600)  Restriction standard is PCT’s “unity of invention,” which may be more liberal than US restriction standard In general, bypass applications are preferable if any revisions need to be made Filing options in the US 14 © AIPLA 2015

Seek (and listen to) advice from your US associates  Do not assume US practice is same as JP practice Send instructions early, give US associates chance to seek clarification/ask questions Provide clear instructions, but allow US associates to exercise their professional judgment and discretion Working with US agents/associates 15 © AIPLA 2015

Yuichi Watanabe Partner Osha Liang LLP Two Houston Center Suite Fannin St. Houston, TX Questions? Please Thank you for your attention! 16 © AIPLA 2015